SCHEMBL6185480

SCHEMBL6185480

CC(C)CNC(=O)O[C@@H](Cc1ccccc1)[C@@H](O)CNCC1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 6/20 0.45
REN P00797 6/20 0.43
CTSD P07339 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5404351 0.86 BCHE (0.43) BCHECTSD
SCHEMBL5404358 0.86 BCHE (0.43) BCHECTSD
SCHEMBL5807717 0.86 LMNA (0.51) RENCTSD
SCHEMBL6187208 0.76 HPGD (0.39)
SCHEMBL30318981 0.73 REN (0.58) REN
SCHEMBL5220702 0.73 REN (0.58) REN
SCHEMBL16912773 0.73 ANPEP (0.46) BCHE
SCHEMBL5930124 0.73 ANPEP (0.46) BCHE
SCHEMBL5930117 0.73 ANPEP (0.46) BCHE
SCHEMBL5960346 0.72 CTSK (0.50) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004050619-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2004-06-17 WO disclosed